Viscosupplementation Treatment For Arthritis Market Report 2026

Viscosupplementation Treatment For Arthritis Market Overview

• Viscosupplementation Treatment For Arthritis market size has reached to $4.18 billion in 2025 • Expected to grow to $5.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.4% • Growth Driver: The Rise In Osteoarthritis Cases Driving The Growth Of The Market Due To Aging Population And Increased Disease Burden • Market Trend: Next-Generation Joint Therapy Offers Enhanced Pain Relief And Mobility For Musculoskeletal Conditions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Viscosupplementation Treatment For Arthritis Market?

Viscosupplementation treatment for arthritis refers to a medical therapy in which a gel-like substance, typically hyaluronic acid, is injected into a joint to improve lubrication and reduce pain. This treatment helps restore the natural cushioning and shock-absorbing properties of the joint, particularly in osteoarthritis. It is often used when conventional treatments, such as pain medications or physical therapy, are insufficient to manage joint discomfort and stiffness. The main product types of viscosupplementation treatment for arthritis are single injection, three injection, and five injections. Single-injection viscosupplementation treatment for arthritis refers to a therapy in which a single dose of hyaluronic acid or a similar lubricant is injected into the joint to reduce pain, improve mobility, and restore joint cushioning. These treatments are used for applications such as knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, and others, and are employed by various end-users, including hospitals, ambulatory surgical centers, orthopedic clinics, and others.

What Is The Viscosupplementation Treatment For Arthritis Market Growth Forecast?

The viscosupplementation treatment for arthritis market size is expected to see strong growth in the next few years. It will grow to $5.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to increasing demand for non-surgical arthritis treatments, rising healthcare expenditure on musculoskeletal disorders, expansion of outpatient orthopedic services, growing focus on quality-of-life improvement, ongoing innovation in viscosupplement formulations. Major trends in the forecast period include growing adoption of single-injection treatment regimens, rising demand for long-lasting pain relief solutions, expansion of minimally invasive arthritis therapies, increased focus on improved joint lubrication formulations, enhanced emphasis on patient-centric treatment approaches.

Global Viscosupplementation Treatment For Arthritis Market Segmentation

1) By Product Type: Single Injection, Three Injections, Five Injections 2) By Application: Knee Osteoarthritis, Hip Osteoarthritis, Shoulder Osteoarthritis, Other Applications 3) By End-User: Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Other End-Users Subsegments: 1) By Single Injection: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid 2) By Three Injections: Standard Hyaluronic Acid, Buffered Hyaluronic Acid, Biofermented Hyaluronic Acid 3) By Five Injections: Cross-Linked High Viscosity Hyaluronic Acid, Extended-Release Hyaluronic Acid, Multi-Dose Hyaluronic Acid

What Are The Drivers Of The Viscosupplementation Treatment For Arthritis Market?

The increasing prevalence of osteoarthritis is expected to propel the growth of the viscosupplementation treatment for the arthritis market going forward. Osteoarthritis refers to a chronic joint disorder characterized by the gradual degeneration of cartilage, leading to pain, stiffness, and reduced mobility. The increasing prevalence of osteoarthritis is primarily due to an aging population, as the natural wear and tear of joints over time makes older adults more susceptible to the disease. Viscosupplementation treatment for arthritis helps manage osteoarthritis by restoring joint lubrication, reducing pain, and improving mobility. For instance, in February 2025, Springer Nature Group, a UK-based academic and professional publishing company, estimated the number of knee osteoarthritis cases at 12.94 million in males and 18.80 million in females. By 2046, these figures are projected to rise to 18.45 million in males and 25.60 million in females. Therefore, increasing prevalence of osteoarthritis is driving the growth of the viscosupplementation treatment for the arthritis market. The rising healthcare expenditure is expected to propel the growth of the viscosupplementation treatment for arthritis market going forward. Healthcare expenditure is increasing due to the growing prevalence of chronic diseases, which require long-term medical management and continuous therapeutic interventions. Healthcare expenditure supports viscosupplementation treatment for arthritis by enabling greater access to advanced therapies, funding innovative research, and improving patient affordability for effective osteoarthritis management. For instance, in June 2025, according to the Centers for Medicare & Medicaid Services, a US-based government agency, in 2023, national health expenditures (NHE) increased by 7.5% to reach $4.9 trillion, averaging $14,570 per person and representing 17.6% of the Gross Domestic Product (GDP). Medicare spending rose by 8.1% to $1,029.8 billion, accounting for 21% of total NHE. Therefore, rising healthcare expenditure is driving the growth of the viscosupplementation treatment for arthritis industry.

Key Players In The Global Viscosupplementation Treatment For Arthritis Market

Major companies operating in the viscosupplementation treatment for arthritis market are Johnson And Johnson, Sanofi S.A., LG Chem Ltd., Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Zimmer Biomet Holdings Inc., IBSA Group, Bioventus Inc., Fidia Farmaceutici S.p.A., Ferring Pharmaceuticals A/S, Anika Therapeutics Inc., TRB Chemedica International S.A., Laboratoires VIVACY, Seikagaku Corporation, Regen Lab SA, Genzyme Corporation, Medtronic PLC, Orthogenix Inc., Hyundai Pharm Co. Ltd., DePuy Synthes

Global Viscosupplementation Treatment For Arthritis Market Trends and Insights

Major companies operating in the viscosupplementation treatment for the arthritis market are focusing on developing innovative solutions such as advanced hyaluronic acid formulations to enhance joint lubrication, reduce pain, and improve mobility. Advanced hyaluronic acid formulations are specially designed versions of hyaluronic acid with improved molecular structure and viscosity to provide longer-lasting joint lubrication and more effective pain relief in arthritis treatment. For instance, in February 2024, IBSA Group, a Switzerland-based pharmaceutical company, launched the SINOVIAL range, a next-generation viscosupplementation treatment for musculoskeletal conditions. This range leverages advanced NAHYCO technology, which combines high and low molecular weight hyaluronic acid to provide effective joint lubrication and extended pain relief. Designed to replicate the functions of natural synovial fluid, these treatments enhance joint cushioning and shock absorption. The injectable formulation offers optimal viscosity and excellent tolerance, supporting improved patient comfort, mobility, and management of osteoarthritis and other musculoskeletal disorders.

Regional Outlook

North America was the largest region in the viscosupplementation treatment for arthritis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Viscosupplementation Treatment For Arthritis Market?

The viscosupplementation treatment for arthritis market consists of revenues earned by entities by providing services such as joint assessment and imaging services, physical therapy support, post-injection monitoring and follow-up, arthroscopic guidance services, and customized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation treatment market also includes sales of hyaluronic acid injections, cross-linked hyaluronic acid formulations, multi-dose hyaluronic acid syringes, combination therapies, and biologically derived viscosupplements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Viscosupplementation Treatment For Arthritis Market Report 2026?

The viscosupplementation treatment for arthritis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the viscosupplementation treatment for arthritis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.